Oncocytic change in pleomorphic adenoma: molecular evidence in support of an origin in neoplastic cells
Open Access
- 25 August 2006
- journal article
- case report
- Published by BMJ in Journal of Clinical Pathology
- Vol. 60 (5), 492-499
- https://doi.org/10.1136/jcp.2005.031369
Abstract
Background: Cells with oncocytic change (OC) are a common finding in salivary glands (SGs) and in SG tumours. When found within pleomorphic adenomas (PAs), cells with OC may be perceived as evidence of malignancy, and lead to a misdiagnosis of carcinoma ex pleomorphic adenoma (CaExPa). Aim: To describe a case of PA with atypical OC, resembling a CaExPa. A genomewide molecular analysis was carried out to compare the molecular genetic features of the two components and to determine whether the oncocytic cells originated from PA cells, entrapped normal cells, or whether these cells constitute an independent tumour. Materials and methods: Representative blocks were immunohistochemically analysed with antibodies raised against cytokeratin (Ck) 5/6, Ck8/18, Ck14, vimentin, p63, α-smooth muscle actin (ASMA), S100 protein, anti-mitochondria antibody, β-catenin, HER2, Ki67, p53 and epidermal growth factor receptor. Typical areas of PA and OC were microdissected and subjected to microarray-based comparative genomic hybridisation (aCGH). Chromogenic in situ hybridisation (CISH) was performed with in-house generated probes to validate the aCGH findings. Results: PA cells showed the typical immunohistochemical profile, including positivity for Ck5/6, Ck8/18, Ck14, vimentin, ASMA, S100 protein, p63, epidermal growth factor receptor and β-catenin, whereas oncocytic cells showed a luminal phenotype, expression of anti-mitochondria antibody and reduced β-catenin staining. Both components showed low proliferation rates and lacked p53 reactivity. aCGH revealed a similar amplification in both components, mapping to 12q13.3–q21.1, which was further validated by CISH. No HER2 gene amplification or overexpression was observed. The foci of oncocytic metaplasia showed an additional low-level gain of 6p25.2–p21.31. Conclusion: The present data demonstrate that the bizarre atypical cells of the present case show evidence of clonality but no features of malignancy. In addition, owing to the presence of a similar genome amplification pattern in both components, it is proposed that at least in some cases, OC may originate from PA cells.Keywords
This publication has 34 references indexed in Scilit:
- Pleomorphic Adenomas of the Salivary Glands: Absence of HMGIY RearrangementsCancer Genetics and Cytogenetics, 1999
- Oncocytic myoepithelioma and pleomorphic adenoma of the salivary glands.Virchows Archiv, 1999
- Oncocytic and oncocytoid tumors of the salivary glands.1999
- Oxyphilic proliferations of the respiratory tract and paranasal sinuses.1999
- Nonsyntenic Amplification of MYC with CDK4 and MDM2 in a Malignant Mixed Tumor of Salivary GlandCancer Genetics and Cytogenetics, 1998
- The human homologue for the Caenorhabditis elegans cul-4 gene is amplified and overexpressed in primary breast cancers.1998
- Molecular characterization of a complex chromosomal rearrangement in a pleomorphic salivary gland adenoma involving the 3′-UTR of HMGICCancer Genetics and Cytogenetics, 1997
- Expression of reciprocal hybrid transcripts of HMGIC and FHIT in a pleomorphic adenoma of the parotid gland.1997
- Gene amplification in human gliomasGlia, 1995
- Oncocytic differentiation in salivary gland tumoursThe Journal of Laryngology & Otology, 1995